WideTrial, Inc.   Report issue

For profit
Founded: South San Francisco CA United States (2017)
Status: No NME R&D (2017)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Alternative names

WideTrial, Inc.

Active Ingredients

Drugs in Other Trials (1)

allogeneic plx-pad cells (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1